Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT03986034 · RECRUITING
Trial details
- NCT number
- NCT03986034
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-26
- Primary completion
- 2026-11-17
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.